MEMPHIS, Tenn.--(BUSINESS WIRE)--PMC Biogenix Inc. announces that effective February 1, 2015 or as contracts permit, prices for Armoslip and Kemamide brand primary and secondary fatty amides and bisamides will increase by 19.8% for all Euro denominated orders. This increase is necessary to counter balance the unprecedented decline in the Euro to dollar exchange rate and preserve our ability to provide the world class service expected by our global customer base.
Customers with questions should contact their local sales manager or the PMC Biogenix customer service group.
PMC Group is a growth oriented, diversified, global chemicals and plastics company dedicated to innovative solutions to everyday needs in a broad range of end markets including plastics, consumer products, electronics, paints, packaging, personal care, food, automotive and pharmaceuticals. The Company was built on a sustainable model of growth through innovation while promoting social good. PMC operates from a global manufacturing, innovation and marketing platform with facilities in the Americas, Europe and Asia. More information about PMC and its activities around the world can be found at www.pmc-group.com.
For a Complete Version of this BUSINESS WIRE Press Release